Dr. Oscar Salamone, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 15066 Rosecrans Ave., La Mirada, CA 90638 Phone: 714-739-2020 Fax: 714-739-2202 |
Dr. Michael Lawrence Byrne, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 12819 Valley View Ave, La Mirada, CA 90638 Phone: 562-921-6659 Fax: 562-921-9374 |
Dr. K. Leo Uyeda, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 14820 Beach Blvd, La Mirada, CA 90638 Phone: 714-522-6703 Fax: 714-522-7623 |
La Mirada Optometry, Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 12819 Valley View Ave, La Mirada, CA 90638 Phone: 562-921-6659 |
Dr. David Edward Mont, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 15076 Imperial Hwy, La Mirada, CA 90638 Phone: 562-943-0386 Fax: 562-943-0912 |
Jennifer Zen Chen, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 15082 Imperial Hwy, La Mirada, CA 90638 Phone: 562-967-2870 |
Ms. Debbie Chen-bennett, OD Optometrist Medicare: Medicare Enrolled Practice Location: 12819 Valley View Ave, La Mirada, CA 90638 Phone: 562-921-6659 |
La Mirada Optometry Optometrist Medicare: Medicare Enrolled Practice Location: 12819 Valley View Ave, La Mirada, CA 90638 Phone: 562-921-6659 Fax: 562-921-6659 |
Dcb Optometry, Inc Optometrist Medicare: Medicare Enrolled Practice Location: 12819 Valley View Ave, La Mirada, CA 90638 Phone: 562-921-6659 Fax: 562-921-9374 |
Dr. Marvin Forman, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 15066 Rosecrans Ave, La Mirada, CA 90638 Phone: 714-739-2020 Fax: 714-739-2202 |
News Archive
StemCells, Inc. announced today that is has received authorization from Swissmedic, the Swiss regulatory agency for therapeutic products, to initiate a Phase I/II clinical trial in Switzerland of the Company's proprietary HuCNS-SCĀ® product candidate (purified human neural stem cells) in chronic spinal cord injury. The trial is designed to assess both safety and preliminary efficacy in patients with varying degrees of paralysis who are three to 12 months post-injury, and will progressively enroll patients based upon the severity of injury.
Cervical cancer can be insidious. Changes to the cervix are often detected with a pap smear, but for those with limited access to health care, cervical and vaginal cancers can go unnoticed for years-silently growing, spreading and invading other organs-and by the time they're detected, they may be so advanced that the patient's prognosis is poor and her treatment options few.
The National Comprehensive Cancer Network (NCCN) recently updated the NCCN Guidelines for Prostate Cancer Early Detection incorporating the results of the recent ERSPC trial that assessed the benefit of PSA screening. The NCCN Guidelines contend that PSA screening does save lives when performed intelligently in men at high-risk of developing the disease.
"Practice makes perfect" seems logical, but how much practice remains uncertain, and current health care quality guidelines may be set too high. It may be time to reexamine the standard recommending hospitals perform at least 400 angioplasty and stent procedures per year, according to a new study in the May 19, 2004 issue of the Journal of the American College of Cardiology.
Oesophageal cancer is a very serious form of cancer that, if not fatal, requires extensive surgery. A new study from Karolinska Institutet in Sweden shows that when serious complications arise after surgery for oesophageal cancer, many patients suffer other health problems, such as breathlessness, fatigue, insomnia and eating problems, for five years afterwards.
› Verified 9 days ago